The Cost Effectiveness of Naltrexone Added to Cognitive-Behavioral Therapy in the Treatment of Alcohol Dependence

REFERENCES

• Collins , D J and Lapsley , H M . 2003 . Counting the cost: estimates of the social costs of drug abuse in Australia in 1998–9 , Canberra : Commonwealth Department of Health and Ageing .
   Google Scholar
• National Expert Advisory Committee on Alcohol 2001 . 2004 . National Alcohol Strategy: a plan for action 2001 to 2003–04 , Canberra : Commonwealth Department of Health and Aged Care .
   Google Scholar
• Miller , W , Brown , J , Simpson , T , Handmaker , N , Bien , T , Luckie , L , Montgomery , H , Hester , R and Tonigan , J . 1995 . “ What works? A methodological analysis of the alcohol treatment and outcome literature ” . In Handbook of alcoholism treatment approaches: effective alternatives, , 2nd ed. , Edited by: Hester , R and Miller , W . 12 – 44 . Boston : Allyn & Bacon .
   Google Scholar
• Morgenstern , J and Longabaugh , R . 2000 . Cognitive-behavioral therapy for alcohol dependence: a review of evidence for its hypothesized mechanism of action . Addiction , 97 : 1475 – 90 .
   Google Scholar
• Project MATCH Research Group . 1997 . Project MATCH secondary a priori hypotheses . Addiction , 92 : 1671 – 98 .
   PubMed Web of Science ®Google Scholar
• Kiefer , F , Jahn , H , Tarnaske , T , Helwig , H , Briken , P Holzbach , R . 2003 . Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism . Arch Gen Psychiatry , 60 : 92 – 9 .
   PubMed Web of Science ®Google Scholar
• Feeney , G FX , Connor , J P , Young , R McD , Tucker , J and McPherson , A . 2006 . Combined acamprosate and naltrexone with Cognitive Behavioural Therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy . Alcohol Alcohol , 41 : 321 – 7 .
   PubMed Web of Science ®Google Scholar
• Sindelar , J L , Jofre-Bonet , M , French , M T and McLellan , A T . 2004 . Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes . Drug Alcohol Depend , 73 : 41 – 50 .
   PubMed Web of Science ®Google Scholar
• French , M T , Salome , H IJ , Sindelar , J L and McLellan , A T . 2002 . Benefit cost analysis of addiction treatment: Methodological guidelines and applications using the DATCAP and ASI . Health Serv Res , 37 : 433 – 55 .
   PubMed Web of Science ®Google Scholar
• Cartwright , W S . 1998 . Cost-benefit and cost-effectiveness analysis of drug abuse treatment services . Eval Rev , 22 : 609 – 36 .
   PubMed Web of Science ®Google Scholar
• Cartwright , W S . 2000 . Cost-benefit and cost-effectiveness analysis of drug treatment services: Review of the literature . Ment Health Policy Econ , 3 : 11 – 26 .
   PubMedGoogle Scholar
• Tella , M N , Feinglass , J and Chang , R W . 2003 . Cost-effective ness, cost-utility, and cost-benefit studies in rheumatology: a review of the literature, 2001–2002 . Curr Opin Rheumatol , 15 : 27 – 131 .
   Web of Science ®Google Scholar
• Cisler , R , Holder , H D , Longabaugh , R , Stout , R L and Zweben , A . 1998 . Actual and estimated replication costs for alcohol treatment modalities: case study from Project MATCH . J Stud Alcohol , 59 : 503 – 12 .
   PubMed Web of Science ®Google Scholar
• Holder , H , Longabaugh , R , Miller , W R and Rubonis , A V . 1991 . The cost effectiveness of treatment for alcoholism: a first approximation . J Stud Alcohol , 52 : 517 – 40 .
   PubMed Web of Science ®Google Scholar
• French , M T . 2000 . Economic evaluation of alcohol treatment services . Eval Program Plann , 23 : 27 – 9 .
   Web of Science ®Google Scholar
• French , M T , Dunlap , L J , Zarkin , G A , McGeary , K A and McLellan , A T . 1997 . A structured instrument for estimating the economic cost of drug abuse treatment: The Drug Abuse Treatment Cost Analysis Program (DATCAP) . J Subst Abuse Treat , 14 : 445 – 55 .
   PubMed Web of Science ®Google Scholar
• Salome , H J , French , M T , Scott , C , Foss , M and Dennis , M . 2003 . Investigating the cost and benefits of addiction treatment: econometric analysis of the Chicago target Cities Project . Eval Program Plann , 26 : 325 – 38 .
   Web of Science ®Google Scholar
• Connor , J P , Saunders , J B and Feeney , G FX . 2006 . “ Quality of Life in Addiction ” . In Quality of life in mental disorders , Edited by: Katschnig , H , Freeman , H and Sartorius , N . 199 – 208 . New York : John Wiley & Sons, Inc. .
   Google Scholar
• Gold , M R , Russell , L B , Siegel , J and Weinsteion , M C . 1996 . Cost-effectiveness in health and medicine , New York : Oxford University Press .
   Google Scholar
• Weinstein , M C , Siegel , J E , Gold , M R , Kamlet , M S and Russell , L B . 1996 . Recommendations of the panel on cost-effectiveness in health and medicine . JAMA , 16 : 1253 – 8 .
   Google Scholar
• Neumann , P J , Goldie , S J and Weinstein , M C . 2000 . Preference-based measures in economic evaluation in health care . Annu Rev Public Health , 21 : 587 – 611 .
   PubMed Web of Science ®Google Scholar
• Deverill , M , Brazier , J , Green , C and Booth , A . 1998 . The use of QALY and Non-QALY measures of health-related quality of life: assessing the state of the art . Pharmacoeconomics , 13 : 411 – 420 .
   PubMed Web of Science ®Google Scholar
• Robinson , R . 1993 . Cost-utility analysis . BMJ , 307 : 859 – 62 .
   PubMed Web of Science ®Google Scholar
• Brazier , J , Usherwood , T , Harper , R and Thomas , K . 1998 . Deriving a preference-based single index from the UK SF-36 Health Survey . J Clin Epidemiol , 51 : 1115 – 28 .
   PubMed Web of Science ®Google Scholar
• Brazier , J , Roberts , J and Deverill , M . 2002 . The estimation of a preference-based measure of health from the SF-36 . J Health Econ , : 271 – 292 .
   PubMed Web of Science ®Google Scholar
• Ware , J E , Snow , K K , Kosinski , M K and Gandek , B . 1993 . SF-36 health survey: manual and interpretation guide , Boston : Health Institute, New England Medical Centre .
   Google Scholar
• Feeney , G FX , Connor , J P , Young , R M , Tucker , J and McPherson , A . 2004 . Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status . Aust N Z J Psychiatry , 38 : 842 – 8 .
   PubMed Web of Science ®Google Scholar
• Doran , C M , Fawcett , J , Shakeshaft , A , Shanahan , M and Mattick , R P . 2003 . New pharmacotherapies for alcohol dependence: are they being used and how what do they cost? . Med J Aust , 179 : 218
   PubMed Web of Science ®Google Scholar
• Pokorny , A D , Miller , B A and Kaplan , H B . 1972 . The Brief MAST: a shortened version of the Michigan Alcoholism Screening Test . Am J Psychiatry , 129 : 342 – 4 .
   PubMed Web of Science ®Google Scholar
• Connor , J P , Grier , M , Feeney , G FX and Young , R McD . 2007 . The validity of the Brief Michigan Alcohol Screening Test (bMAST) as a problem drinking severity measure . J Stud Alcohol Drugs , 68 : 771 – 9 .
   PubMed Web of Science ®Google Scholar
• Donovan , D M , Kadden , R M , DiClemente , C C and Carroll , K M . 2002 . Client satisfaction with three therapies in the treatment of alcohol dependence: results from project MATCH . Am J Ad , 11 : 291 – 307 .
   PubMed Web of Science ®Google Scholar
• Bandura , A . 1997 . Self-efficacy: the exercise of control , New York : Freeman .
   Google Scholar
• Bouza , C , Angeles , M , Munoz , A and Amate , J M . 2004 . Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review . Addiction , 99 : 811 – 28 .
   PubMed Web of Science ®Google Scholar
• Feeney , G FX , Young , R McD , Connor , J P , Tucker , J and McPherson , A . 2001 . Outpatient cognitive behavioural therapy (CBT) program for alcohol dependence: impact of Naltrexone use on outcome . Aust N Z J Psychiatry , 35 : 443 – 8 .
   PubMed Web of Science ®Google Scholar
• Sobell , L C and Sobell , M B . 1996 . Alcohol timeline followback (TLFB) users manual , Toronto : Addiction Research Foundation .
   Google Scholar
• Koch , H , Meerkerk , G , Zaat , J OM , Ham , M F , Scholten , R JPM and Assendelft , W JJ . 2004 . Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review . Alcohol , 39 : 75 – 85 .
   Web of Science ®Google Scholar
• Böhmer , S , Kohlmann , T and Brazier , J . 2002 . Sensitivity to change of the SF-3D in patients with osteoarthritis of hip or knee . Qual Life Res , 11 : 662
   Google Scholar
• Longworth , L and Bryan , S . 2003 . An empirical comparison of EQ-5D and SF-6D in liver transplant patients . Health Econ , 12 : 1061 – 7 .
   PubMed Web of Science ®Google Scholar
• Streeton , C and Whelan , G . 2001 . Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials . Alcohol , 36 : 544 – 52 .
   Web of Science ®Google Scholar
• Briggs , A H and O'Brien , B J . 2001 . The death of cost minimization analysis? . Health Economics , 10 : 179 – 84 .
   PubMed Web of Science ®Google Scholar
• Feeney , G FX , Connor , J P , Young , R McD , Tucker , J and Czajkowski , F . 2001 . Adherence with Naltrexone prescription advice in hospital outpatient alcohol rehabilitation program . J Clin Pharm Ther , 26 : 73 – 9 .
   PubMed Web of Science ®Google Scholar
• Anton , R F , Moak , D H , Waid , L R , Latham , P K , Malcolm , R J and Dias , J K . 1999 . Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial . Am J Psychiatry , 156 : 1758 – 64 .
   PubMed Web of Science ®Google Scholar